Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Stein, D. | Schoebel, F.C. | Heins, M. | Steinmetz, A. | Kaffamik, H. | Uhlich, D. | Leschke, M. | Strauer, B.E.
Affiliations: Medizinische Klinik und Poliklinik B- Klinik für Kardiologie, Pulmonologie und Angiologie | Institut für Klinische Chemie der Heinrich-Heine-Universität Düsseldorf | Zentrum für Innere Medizin Klinikum der Philipps Universität Marburg
Abstract: Restenosis after primarily successful percutaneous transluminal coronary angioplasty (PTCA), which occurs in about 30–40 % of the cases remains a major limiting factor of this procedure. In order to study the possible association of the incidence of restenosis and established risk factors of coronary artery disease levels of lipoprotein(a) (Lp(a)), fibrinogen, total cholesterol, HDL-cholesterol, LDL-cholesterol as well as the plasma viscosity were determined in 98 patients who all had undergone follow-up coronary angiography within 6 ± 2 months after PTCA. Clinical parameters, baseline coronary angiography findings as well as the lipid-lowering medication (administered to 45 % of the patients) were not significantly different between the group of patients with restenosis (n=45) and without restenosis (n=53). A significantly higher risk of restenosis after PTCA was found in patients with Lp(a) levels exceeding 3mg/dl as well as in patients with extensively elevated fibrinogen concentrations (> 400 mg/dl) whereas plasma viscosity showed no differences between patients with and without restenosis after PTCA. While there was no association between the frequency of restenosis and conventional lipid parameters low levels of Lp(a) and very elevated levels of fibrinogen seem to be predictors for an increased risk of restenosis after primarily successful PTCA.
Keywords: Coronary artery disease, Lipoprotein(a), Fibrinogeifercutaneous transluminal coronary angioplasty, Plasma viscosity, Restenosis
DOI: 10.3233/CH-1995-15505
Journal: Clinical Hemorheology and Microcirculation, vol. 15, no. 5, pp. 737-747, 1995
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl